REvisiting Lipids in REtinal Diseases: A Focused Review on Age-related Macular Degeneration and Diabetic Retinopathy

Dyslipidemia refers to an abnormal amount of lipid in the blood, and the total cholesterol level is defined as the sum of high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, and very-LDL cholesterol concentrations. In Korea, the westernization of lifestyle habits in rece...

Full description

Saved in:
Bibliographic Details
Published inJournal of lipid and atherosclerosis Vol. 9; no. 3; pp. 406 - 418
Main Authors Park, Su Jin, Park, Dong Ho
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society of Lipidology and Atherosclerosis 01.09.2020
한국지질동맥경화학회
Subjects
Review
내과학
Diabetic retinopathy
Hypolipidemic agents
Lipids
Age-related macular degeneration
Cholesterol
Online AccessGet full text
ISSN2287-2892
2288-2561
DOI10.12997/jla.2020.9.3.406

Cover

Abstract Dyslipidemia refers to an abnormal amount of lipid in the blood, and the total cholesterol level is defined as the sum of high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, and very-LDL cholesterol concentrations. In Korea, the westernization of lifestyle habits in recent years has caused an increase in the incidence of dyslipidemia, which is an important risk factor of cardiovascular disease (CVD). Several studies have been conducted on how dyslipidemia affects not only CVD, but also chorioretinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Recently, a pathological model of AMD was proposed under the assumption that AMD proceeds through a mechanism similar to that of atherosclerotic CVD. However, controversy remains regarding the relationship between chorioretinal diseases and lipid levels in the blood, and the effects of lipid-lowering agents. Herein, we summarize the role of lipids in chorioretinal diseases. In addition, the effects of lipid-lowering agents on the prevention and progression of chorioretinal diseases are presented.
AbstractList Dyslipidemia refers to an abnormal amount of lipid in the blood, and the total cholesterol level is defined as the sum of high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, and very-LDL cholesterol concentrations. In Korea, the westernization of lifestyle habits in recent years has caused an increase in the incidence of dyslipidemia, which is an important risk factor of cardiovascular disease (CVD). Several studies have been conducted on how dyslipidemia affects not only CVD, but also chorioretinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Recently, a pathological model of AMD was proposed under the assumption that AMD proceeds through a mechanism similar to that of atherosclerotic CVD. However, controversy remains regarding the relationship between chorioretinal diseases and lipid levels in the blood, and the effects of lipid-lowering agents. Herein, we summarize the role of lipids in chorioretinal diseases. In addition, the effects of lipid-lowering agents on the prevention and progression of chorioretinal diseases are presented. KCI Citation Count: 0
Dyslipidemia refers to an abnormal amount of lipid in the blood, and the total cholesterol level is defined as the sum of high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, and very-LDL cholesterol concentrations. In Korea, the westernization of lifestyle habits in recent years has caused an increase in the incidence of dyslipidemia, which is an important risk factor of cardiovascular disease (CVD). Several studies have been conducted on how dyslipidemia affects not only CVD, but also chorioretinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Recently, a pathological model of AMD was proposed under the assumption that AMD proceeds through a mechanism similar to that of atherosclerotic CVD. However, controversy remains regarding the relationship between chorioretinal diseases and lipid levels in the blood, and the effects of lipid-lowering agents. Herein, we summarize the role of lipids in chorioretinal diseases. In addition, the effects of lipid-lowering agents on the prevention and progression of chorioretinal diseases are presented.
Dyslipidemia refers to an abnormal amount of lipid in the blood, and the total cholesterol level is defined as the sum of high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, and very-LDL cholesterol concentrations. In Korea, the westernization of lifestyle habits in recent years has caused an increase in the incidence of dyslipidemia, which is an important risk factor of cardiovascular disease (CVD). Several studies have been conducted on how dyslipidemia affects not only CVD, but also chorioretinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Recently, a pathological model of AMD was proposed under the assumption that AMD proceeds through a mechanism similar to that of atherosclerotic CVD. However, controversy remains regarding the relationship between chorioretinal diseases and lipid levels in the blood, and the effects of lipid-lowering agents. Herein, we summarize the role of lipids in chorioretinal diseases. In addition, the effects of lipid-lowering agents on the prevention and progression of chorioretinal diseases are presented.Dyslipidemia refers to an abnormal amount of lipid in the blood, and the total cholesterol level is defined as the sum of high-density lipoprotein cholesterol, low-density lipoprotein (LDL) cholesterol, and very-LDL cholesterol concentrations. In Korea, the westernization of lifestyle habits in recent years has caused an increase in the incidence of dyslipidemia, which is an important risk factor of cardiovascular disease (CVD). Several studies have been conducted on how dyslipidemia affects not only CVD, but also chorioretinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy. Recently, a pathological model of AMD was proposed under the assumption that AMD proceeds through a mechanism similar to that of atherosclerotic CVD. However, controversy remains regarding the relationship between chorioretinal diseases and lipid levels in the blood, and the effects of lipid-lowering agents. Herein, we summarize the role of lipids in chorioretinal diseases. In addition, the effects of lipid-lowering agents on the prevention and progression of chorioretinal diseases are presented.
Author Park, Su Jin
Park, Dong Ho
AuthorAffiliation Department of Ophthalmology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea
AuthorAffiliation_xml – name: Department of Ophthalmology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea
Author_xml – sequence: 1
  givenname: Su Jin
  orcidid: 0000-0001-8313-7640
  surname: Park
  fullname: Park, Su Jin
  organization: Department of Ophthalmology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea
– sequence: 2
  givenname: Dong Ho
  orcidid: 0000-0001-6911-3765
  surname: Park
  fullname: Park, Dong Ho
  organization: Department of Ophthalmology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33024733$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002626964$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1kk9v1DAQxS1UREvpB-CCcoTDBv9JYpsD0qrdlkqLkFblbM3ak63brLPYyaJ-e9xsiwAJX2yN3_vNyH6vyVHoAxLyltGSca3lx7sOSk45LXUpyoo2L8gJ50rNeN2wo-ksZ1xpfkzOUrqjeemK00a-IsdCUF5JIU7IsFrsffKDD5ti6XfepcKHYrXIBeiKC58QEqZPxby47O2Y0BUr3Hv8WfShmG9wFrGDIVe_gh07iMUFbjBghMFnAQSXEbDGwdvsy8x-B8PtwxvysoUu4dnTfkq-Xy5uzr_Mlt-urs_ny5kVlWry8FYyyBMzpExaQV1rK65bAXUuVJYCOFs3ijulmka5likHa45147RE1ohT8uHADbE199abHvy0b3pzH818dXNtdC0lVzxrPx-0u3G9RWcxDBE6s4t-C_Fhcv59E_xt5uyNrDnTss6A90-A2P8YMQ1m65PFroOA_ZgMryrNpKyoyNJ3f_b63eT5W7JAHgQ29ilFbI31w_SmubXvDKNmyoDJGTCPGTDaCJMzkJ3sH-cz_P-eX5h4tPY
CitedBy_id crossref_primary_10_1007_s13273_022_00272_8
crossref_primary_10_1136_bjo_2023_323792
crossref_primary_10_3390_biomedicines12122828
crossref_primary_10_1016_j_jlr_2023_100343
crossref_primary_10_1016_j_isci_2023_106777
Cites_doi 10.1016/j.exer.2004.09.017
10.1167/iovs.11-7598
10.1136/bjo.59.11.631
10.1016/S0161-6420(92)31982-7
10.3126/nepjoph.v4i1.5846
10.1016/j.ajo.2014.05.027
10.1001/archopht.125.8.1096
10.1016/S0161-6420(91)32186-9
10.1177/1073858410373835
10.1016/S0161-6420(03)00475-5
10.1111/j.1365-2796.2005.01556.x
10.1016/0002-9343(65)90082-3
10.2337/dc08-9018
10.1136/bjophthalmol-2011-300726
10.2337/diabetes.53.11.2883
10.1016/S0140-6736(98)07019-6
10.1076/opep.8.4.237.1613
10.1073/pnas.1401191111
10.1016/j.survophthal.2004.12.002
10.3390/metabo9070127
10.1016/j.ebiom.2016.01.033
10.1136/bjophthalmol-2011-300344
10.1016/S0002-9394(99)00222-6
10.1097/IAE.0b013e31827e25e0
10.1126/science.294.5545.1354
10.1038/eye.1991.128
10.1016/S0161-6420(02)01448-3
10.1039/c0mb00341g
10.1136/bjo.2006.093856
10.1016/j.ajo.2003.09.015
10.1097/00006982-199414020-00006
10.1136/bjo.84.8.871
10.1111/j.0954-6820.1963.tb07936.x
10.1136/bjo.2008.144006
10.1001/archopht.117.3.329
10.1097/00006982-200507001-00015
10.1111/j.1464-5491.2005.01484.x
10.1016/S0161-6420(84)34098-2
10.1194/jlr.R010538
10.1007/s10238-004-0054-z
10.1136/bjo.2003.036277
10.1056/NEJM199309303291401
10.1007/978-1-4419-1399-9_55
10.1001/archopht.1996.01100130476025
10.1001/archopht.1996.01100140281004
10.1038/srep38342
10.1016/S0140-6736(07)61607-9
10.1016/S0140-6736(04)16895-5
10.1016/j.ophtha.2012.10.036
10.1038/eye.2014.8
10.1161/01.ATV.15.5.551
10.1056/NEJMoa0706245
10.1016/S0002-9394(14)74549-0
10.1016/j.ophtha.2012.11.003
10.1001/archopht.1992.01080240041025
10.1016/S1350-9462(00)00025-2
10.1016/j.preteyeres.2009.08.001
10.1016/j.ophtha.2003.10.024
10.3928/15428877-20100430-04
10.1001/archopht.1991.01080030122052
10.1001/archopht.118.3.351
10.1080/07853890701749209
10.1371/journal.pone.0083759
10.1016/j.ophtha.2010.07.009
10.1016/S0140-6736(62)92422-4
10.1007/BF02154735
10.1371/journal.pone.0196037
10.1016/S1056-8727(01)00140-4
10.1016/S0140-6736(09)62124-3
10.1161/circ.106.25.3143
10.1016/S0009-8981(02)00288-7
10.1016/j.ophtha.2009.09.005
10.1194/jlr.R800054-JLR200
10.1016/S0140-6736(08)61759-6
10.1016/S0161-6420(13)38012-9
10.1016/S0140-6736(04)17018-9
10.2337/diab.17.7.458
10.1111/j.1442-9071.1980.tb01670.x
10.1001/archopht.121.8.1151
10.1016/j.jacc.2004.07.001
10.1001/jamaophthalmol.2014.5108
10.1016/S2213-8587(14)70173-1
10.1016/S0168-8227(01)00341-2
10.1161/01.ATV.8.2.103
10.1016/j.exer.2005.11.018
10.1136/bjo.83.3.358
10.1016/S2214-109X(13)70145-1
10.1038/nrd1901
10.1136/bjo.60.5.324
10.1056/NEJMoa1001288
10.1073/pnas.1620898114
10.1136/bmj.317.7160.703
ContentType Journal Article
Copyright Copyright © 2020 The Korean Society of Lipid and Atherosclerosis.
Copyright © 2020 The Korean Society of Lipid and Atherosclerosis. 2020 The Korean Society of Lipid and Atherosclerosis
Copyright_xml – notice: Copyright © 2020 The Korean Society of Lipid and Atherosclerosis.
– notice: Copyright © 2020 The Korean Society of Lipid and Atherosclerosis. 2020 The Korean Society of Lipid and Atherosclerosis
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.12997/jla.2020.9.3.406
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2288-2561
EndPage 418
ExternalDocumentID oai_kci_go_kr_ARTI_9577282
PMC7521975
33024733
10_12997_jla_2020_9_3_406
Genre Journal Article
Review
GrantInformation_xml – fundername: ;
  grantid: 2019R1A2C1084371
– fundername: ;
  grantid: HI16C1501
GroupedDBID 5-W
53G
8JR
8XY
AAYXX
ALMA_UNASSIGNED_HOLDINGS
CITATION
EF.
GROUPED_DOAJ
OK1
PGMZT
RPM
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c3486-28c71a0671e017c30dfc429f3a5e014c0aadc5682d88668df18dab2e56d97e163
ISSN 2287-2892
IngestDate Sun Mar 09 07:54:28 EDT 2025
Thu Aug 21 14:32:22 EDT 2025
Fri Jul 11 04:17:36 EDT 2025
Thu Jan 02 22:40:02 EST 2025
Thu Apr 24 23:08:14 EDT 2025
Tue Jul 01 00:25:34 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Diabetic retinopathy
Hypolipidemic agents
Lipids
Age-related macular degeneration
Cholesterol
Language English
License Copyright © 2020 The Korean Society of Lipid and Atherosclerosis.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3486-28c71a0671e017c30dfc429f3a5e014c0aadc5682d88668df18dab2e56d97e163
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
https://e-jla.org/DOIx.php?id=10.12997/jla.2020.9.3.406
ORCID 0000-0001-6911-3765
0000-0001-8313-7640
OpenAccessLink http://dx.doi.org/10.12997/jla.2020.9.3.406
PMID 33024733
PQID 2449177403
PQPubID 23479
PageCount 13
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9577282
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7521975
proquest_miscellaneous_2449177403
pubmed_primary_33024733
crossref_citationtrail_10_12997_jla_2020_9_3_406
crossref_primary_10_12997_jla_2020_9_3_406
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20200901
PublicationDateYYYYMMDD 2020-09-01
PublicationDate_xml – month: 9
  year: 2020
  text: 20200901
  day: 1
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of lipid and atherosclerosis
PublicationTitleAlternate J Lipid Atheroscler
PublicationYear 2020
Publisher Korean Society of Lipidology and Atherosclerosis
한국지질동맥경화학회
Publisher_xml – name: Korean Society of Lipidology and Atherosclerosis
– name: 한국지질동맥경화학회
References Narang (10.12997/jla.2020.9.3.406_ref95) 2012; 4
Klein (10.12997/jla.2020.9.3.406_ref79) 2015; 133
Wilkinson (10.12997/jla.2020.9.3.406_ref67) 2003; 110
Yusuf (10.12997/jla.2020.9.3.406_ref2) 2004; 364
Klein (10.12997/jla.2020.9.3.406_ref100) 1999; 128
Brown (10.12997/jla.2020.9.3.406_ref76) 1984; 91
Tserentsoodol (10.12997/jla.2020.9.3.406_ref15) 2006; 12
Klein (10.12997/jla.2020.9.3.406_ref45) 2003; 110
Liinamaa (10.12997/jla.2020.9.3.406_ref89) 2008; 40
van Leeuwen (10.12997/jla.2020.9.3.406_ref63) 2004; 111
Fliesler (10.12997/jla.2020.9.3.406_ref13) 2010; 51
Miljanovic (10.12997/jla.2020.9.3.406_ref99) 2004; 53
van der Schaft (10.12997/jla.2020.9.3.406_ref30) 1992; 99
Green (10.12997/jla.2020.9.3.406_ref24) 2005; 25
Denniston (10.12997/jla.2020.9.3.406_ref88) 2005; 22
Fliesler (10.12997/jla.2020.9.3.406_ref12) 2010
Hyman (10.12997/jla.2020.9.3.406_ref47) 2000; 118
Cheung (10.12997/jla.2020.9.3.406_ref66) 2010; 376
Olofsson (10.12997/jla.2020.9.3.406_ref38) 2005; 258
Wong (10.12997/jla.2020.9.3.406_ref17) 2014; 2
Li (10.12997/jla.2020.9.3.406_ref83) 2011; 7
Grundy (10.12997/jla.2020.9.3.406_ref4) 2004; 44
Mauch (10.12997/jla.2020.9.3.406_ref7) 2001; 294
Sen (10.12997/jla.2020.9.3.406_ref92) 2002; 56
Laíns (10.12997/jla.2020.9.3.406_ref53) 2019; 9
Mitchell (10.12997/jla.2020.9.3.406_ref68) 2012; 96
Löffler (10.12997/jla.2020.9.3.406_ref25) 1986; 224
Coleman (10.12997/jla.2020.9.3.406_ref19) 2008; 372
Curcio (10.12997/jla.2020.9.3.406_ref37) 2009; 28
Williams (10.12997/jla.2020.9.3.406_ref36) 1995; 15
Nowak (10.12997/jla.2020.9.3.406_ref49) 2005; 4
Gaede (10.12997/jla.2020.9.3.406_ref86) 2008; 358
Chew (10.12997/jla.2020.9.3.406_ref94) 2010; 363
Dashti (10.12997/jla.2020.9.3.406_ref40) 2006; 90
UK Prospective Diabetes Study Group (10.12997/jla.2020.9.3.406_ref73) 1998; 317
Diabetes Control and Complications Trial Research Group (10.12997/jla.2020.9.3.406_ref71) 1993; 329
Guymer (10.12997/jla.2020.9.3.406_ref62) 2013; 8
Small (10.12997/jla.2020.9.3.406_ref35) 1988; 8
Curcio (10.12997/jla.2020.9.3.406_ref33) 2005; 80
Zander (10.12997/jla.2020.9.3.406_ref70) 2000; 84
Curcio (10.12997/jla.2020.9.3.406_ref39) 2011; 95
Curcio (10.12997/jla.2020.9.3.406_ref32) 1999; 117
Keech (10.12997/jla.2020.9.3.406_ref93) 2007; 370
Wengrofsky (10.12997/jla.2020.9.3.406_ref10) 2019
Li (10.12997/jla.2020.9.3.406_ref54) 2016; 6
Brunzell (10.12997/jla.2020.9.3.406_ref5) 2008; 31
Brown (10.12997/jla.2020.9.3.406_ref9) 2009; 50
Guerci (10.12997/jla.2020.9.3.406_ref82) 1999; 25
Yanai (10.12997/jla.2020.9.3.406_ref50) 2014; 111
Raman (10.12997/jla.2020.9.3.406_ref81) 2010; 117
Abalain (10.12997/jla.2020.9.3.406_ref48) 2002; 326
Oliver (10.12997/jla.2020.9.3.406_ref84) 1962; 1
Lee (10.12997/jla.2020.9.3.406_ref6) 2006; 83
Sarks (10.12997/jla.2020.9.3.406_ref27) 1976; 60
Panagiotoglou (10.12997/jla.2020.9.3.406_ref91) 2010; 41
Nielsen (10.12997/jla.2020.9.3.406_ref87) 2014; 2
Hasegawa (10.12997/jla.2020.9.3.406_ref51) 2017; 114
Vavvas (10.12997/jla.2020.9.3.406_ref60) 2016; 5
Bressler (10.12997/jla.2020.9.3.406_ref31) 1994; 14
Penfold (10.12997/jla.2020.9.3.406_ref58) 2001; 20
Saher (10.12997/jla.2020.9.3.406_ref8) 2011; 17
Reynolds (10.12997/jla.2020.9.3.406_ref43) 2010; 117
Feeney-Burns (10.12997/jla.2020.9.3.406_ref23) 1990; 109
Rosa (10.12997/jla.2020.9.3.406_ref26) 1996; 114
Yanai (10.12997/jla.2020.9.3.406_ref52) 2018; 13
Guymer (10.12997/jla.2020.9.3.406_ref56) 2005; 50
Resnikoff (10.12997/jla.2020.9.3.406_ref18) 2004; 82
Zhang (10.12997/jla.2020.9.3.406_ref90) 2007; 125
Benarous (10.12997/jla.2020.9.3.406_ref80) 2011; 52
Cetin (10.12997/jla.2020.9.3.406_ref78) 2013; 6
Fried (10.12997/jla.2020.9.3.406_ref97) 2001; 15
Chew (10.12997/jla.2020.9.3.406_ref98) 1996; 114
Sarks (10.12997/jla.2020.9.3.406_ref28) 1980; 8
Duncan (10.12997/jla.2020.9.3.406_ref85) 1968; 17
van der Schaft (10.12997/jla.2020.9.3.406_ref29) 1991; 109
Delcourt (10.12997/jla.2020.9.3.406_ref46) 2001; 8
Jain (10.12997/jla.2020.9.3.406_ref55) 2005; 4
Friedman (10.12997/jla.2020.9.3.406_ref57) 2004; 88
Guyton (10.12997/jla.2020.9.3.406_ref34) 1989; 134
Hayreh (10.12997/jla.2020.9.3.406_ref11) 1975; 59
(10.12997/jla.2020.9.3.406_ref69) 1991; 98
Esmann (10.12997/jla.2020.9.3.406_ref74) 1963; 174
Colhoun (10.12997/jla.2020.9.3.406_ref96) 2004; 364
Elner (10.12997/jla.2020.9.3.406_ref14) 2002; 100
Duncan (10.12997/jla.2020.9.3.406_ref16) 2009; 93
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (10.12997/jla.2020.9.3.406_ref3) 2002; 106
van Leeuwen (10.12997/jla.2020.9.3.406_ref44) 2004; 137
Klein (10.12997/jla.2020.9.3.406_ref41) 2013; 120
Klein (10.12997/jla.2020.9.3.406_ref65) 2014; 158
Ferris (10.12997/jla.2020.9.3.406_ref20) 2013; 120
Klein (10.12997/jla.2020.9.3.406_ref21) 1991; 98
Barbosa (10.12997/jla.2020.9.3.406_ref61) 2014; 28
The Korean Society of Lipid and Atherosclerosis (10.12997/jla.2020.9.3.406_ref1) 2018
(10.12997/jla.2020.9.3.406_ref72) 1998; 352
Ernest (10.12997/jla.2020.9.3.406_ref75) 1965; 39
(10.12997/jla.2020.9.3.406_ref42) 1992; 110
Klein (10.12997/jla.2020.9.3.406_ref64) 2003; 121
Curcio (10.12997/jla.2020.9.3.406_ref59) 2013; 33
Sarks (10.12997/jla.2020.9.3.406_ref22) 1999; 83
Dodson (10.12997/jla.2020.9.3.406_ref77) 1991; 5
References_xml – volume: 80
  start-page: 761
  year: 2005
  ident: 10.12997/jla.2020.9.3.406_ref33
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2004.09.017
– volume: 52
  start-page: 7464
  year: 2011
  ident: 10.12997/jla.2020.9.3.406_ref80
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.11-7598
– volume: 59
  start-page: 631
  year: 1975
  ident: 10.12997/jla.2020.9.3.406_ref11
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.59.11.631
– volume: 99
  start-page: 278
  year: 1992
  ident: 10.12997/jla.2020.9.3.406_ref30
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(92)31982-7
– volume: 25
  start-page: 412
  year: 1999
  ident: 10.12997/jla.2020.9.3.406_ref82
  publication-title: Diabetes Metab
– volume-title: Dyslipidemia fact sheets in Korea 2018
  year: 2018
  ident: 10.12997/jla.2020.9.3.406_ref1
– volume: 4
  start-page: 23
  year: 2012
  ident: 10.12997/jla.2020.9.3.406_ref95
  publication-title: Nepal J Ophthalmol
  doi: 10.3126/nepjoph.v4i1.5846
– volume: 158
  start-page: 513
  year: 2014
  ident: 10.12997/jla.2020.9.3.406_ref65
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2014.05.027
– volume: 125
  start-page: 1096
  year: 2007
  ident: 10.12997/jla.2020.9.3.406_ref90
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.125.8.1096
– volume: 98
  start-page: 1128
  year: 1991
  ident: 10.12997/jla.2020.9.3.406_ref21
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(91)32186-9
– volume: 17
  start-page: 79
  year: 2011
  ident: 10.12997/jla.2020.9.3.406_ref8
  publication-title: Neuroscientist
  doi: 10.1177/1073858410373835
– volume: 110
  start-page: 1677
  year: 2003
  ident: 10.12997/jla.2020.9.3.406_ref67
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(03)00475-5
– volume: 258
  start-page: 395
  year: 2005
  ident: 10.12997/jla.2020.9.3.406_ref38
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2005.01556.x
– volume: 39
  start-page: 594
  year: 1965
  ident: 10.12997/jla.2020.9.3.406_ref75
  publication-title: Am J Med
  doi: 10.1016/0002-9343(65)90082-3
– volume: 31
  start-page: 811
  year: 2008
  ident: 10.12997/jla.2020.9.3.406_ref5
  publication-title: Diabetes Care
  doi: 10.2337/dc08-9018
– volume: 96
  start-page: 688
  year: 2012
  ident: 10.12997/jla.2020.9.3.406_ref68
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjophthalmol-2011-300726
– volume: 53
  start-page: 2883
  year: 2004
  ident: 10.12997/jla.2020.9.3.406_ref99
  publication-title: Diabetes
  doi: 10.2337/diabetes.53.11.2883
– volume: 352
  start-page: 837
  year: 1998
  ident: 10.12997/jla.2020.9.3.406_ref72
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)07019-6
– volume: 8
  start-page: 237
  year: 2001
  ident: 10.12997/jla.2020.9.3.406_ref46
  publication-title: Ophthalmic Epidemiol
  doi: 10.1076/opep.8.4.237.1613
– volume: 111
  start-page: 9603
  year: 2014
  ident: 10.12997/jla.2020.9.3.406_ref50
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1401191111
– volume: 50
  start-page: 194
  year: 2005
  ident: 10.12997/jla.2020.9.3.406_ref56
  publication-title: Surv Ophthalmol
  doi: 10.1016/j.survophthal.2004.12.002
– volume: 9
  start-page: 127
  year: 2019
  ident: 10.12997/jla.2020.9.3.406_ref53
  publication-title: Metabolites
  doi: 10.3390/metabo9070127
– volume: 5
  start-page: 198
  year: 2016
  ident: 10.12997/jla.2020.9.3.406_ref60
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2016.01.033
– volume: 95
  start-page: 1638
  year: 2011
  ident: 10.12997/jla.2020.9.3.406_ref39
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjophthalmol-2011-300344
– volume: 128
  start-page: 652
  year: 1999
  ident: 10.12997/jla.2020.9.3.406_ref100
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(99)00222-6
– volume: 33
  start-page: 265
  year: 2013
  ident: 10.12997/jla.2020.9.3.406_ref59
  publication-title: Retina
  doi: 10.1097/IAE.0b013e31827e25e0
– volume: 294
  start-page: 1354
  year: 2001
  ident: 10.12997/jla.2020.9.3.406_ref7
  publication-title: Science
  doi: 10.1126/science.294.5545.1354
– volume: 5
  start-page: 699
  year: 1991
  ident: 10.12997/jla.2020.9.3.406_ref77
  publication-title: Eye (Lond)
  doi: 10.1038/eye.1991.128
– volume: 134
  start-page: 705
  year: 1989
  ident: 10.12997/jla.2020.9.3.406_ref34
  publication-title: Am J Pathol
– volume: 110
  start-page: 636
  year: 2003
  ident: 10.12997/jla.2020.9.3.406_ref45
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(02)01448-3
– volume: 7
  start-page: 2228
  year: 2011
  ident: 10.12997/jla.2020.9.3.406_ref83
  publication-title: Mol Biosyst
  doi: 10.1039/c0mb00341g
– volume: 90
  start-page: 1028
  year: 2006
  ident: 10.12997/jla.2020.9.3.406_ref40
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2006.093856
– volume: 137
  start-page: 750
  year: 2004
  ident: 10.12997/jla.2020.9.3.406_ref44
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2003.09.015
– volume: 14
  start-page: 130
  year: 1994
  ident: 10.12997/jla.2020.9.3.406_ref31
  publication-title: Retina
  doi: 10.1097/00006982-199414020-00006
– volume: 84
  start-page: 871
  year: 2000
  ident: 10.12997/jla.2020.9.3.406_ref70
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.84.8.871
– volume: 174
  start-page: 375
  year: 1963
  ident: 10.12997/jla.2020.9.3.406_ref74
  publication-title: Acta Med Scand
  doi: 10.1111/j.0954-6820.1963.tb07936.x
– volume: 93
  start-page: 1116
  year: 2009
  ident: 10.12997/jla.2020.9.3.406_ref16
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2008.144006
– volume: 117
  start-page: 329
  year: 1999
  ident: 10.12997/jla.2020.9.3.406_ref32
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.117.3.329
– volume: 12
  start-page: 1306
  year: 2006
  ident: 10.12997/jla.2020.9.3.406_ref15
  publication-title: Mol Vis
– volume: 25
  start-page: 1519
  year: 2005
  ident: 10.12997/jla.2020.9.3.406_ref24
  publication-title: Retina
  doi: 10.1097/00006982-200507001-00015
– volume: 22
  start-page: 665
  year: 2005
  ident: 10.12997/jla.2020.9.3.406_ref88
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2005.01484.x
– volume: 91
  start-page: 1490
  year: 1984
  ident: 10.12997/jla.2020.9.3.406_ref76
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(84)34098-2
– volume: 51
  start-page: 3399
  year: 2010
  ident: 10.12997/jla.2020.9.3.406_ref13
  publication-title: J Lipid Res
  doi: 10.1194/jlr.R010538
– volume: 4
  start-page: 183
  year: 2005
  ident: 10.12997/jla.2020.9.3.406_ref49
  publication-title: Clin Exp Med
  doi: 10.1007/s10238-004-0054-z
– volume: 88
  start-page: 161
  year: 2004
  ident: 10.12997/jla.2020.9.3.406_ref57
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2003.036277
– volume: 329
  start-page: 977
  year: 1993
  ident: 10.12997/jla.2020.9.3.406_ref71
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199309303291401
– start-page: 481
  volume-title: Retinal degenerative diseases: laboratory and therapeutic investigations
  year: 2010
  ident: 10.12997/jla.2020.9.3.406_ref12
  doi: 10.1007/978-1-4419-1399-9_55
– volume: 114
  start-page: 480
  year: 1996
  ident: 10.12997/jla.2020.9.3.406_ref26
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1996.01100130476025
– volume: 114
  start-page: 1079
  year: 1996
  ident: 10.12997/jla.2020.9.3.406_ref98
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1996.01100140281004
– volume: 6
  start-page: 38342
  year: 2016
  ident: 10.12997/jla.2020.9.3.406_ref54
  publication-title: Sci Rep
  doi: 10.1038/srep38342
– volume: 370
  start-page: 1687
  year: 2007
  ident: 10.12997/jla.2020.9.3.406_ref93
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)61607-9
– volume: 364
  start-page: 685
  year: 2004
  ident: 10.12997/jla.2020.9.3.406_ref96
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)16895-5
– volume: 120
  start-page: 844
  year: 2013
  ident: 10.12997/jla.2020.9.3.406_ref20
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2012.10.036
– volume: 28
  start-page: 472
  year: 2014
  ident: 10.12997/jla.2020.9.3.406_ref61
  publication-title: Eye (Lond)
  doi: 10.1038/eye.2014.8
– volume: 15
  start-page: 551
  year: 1995
  ident: 10.12997/jla.2020.9.3.406_ref36
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.15.5.551
– volume: 358
  start-page: 580
  year: 2008
  ident: 10.12997/jla.2020.9.3.406_ref86
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0706245
– volume: 109
  start-page: 265
  year: 1990
  ident: 10.12997/jla.2020.9.3.406_ref23
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(14)74549-0
– volume: 120
  start-page: 1012
  year: 2013
  ident: 10.12997/jla.2020.9.3.406_ref41
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2012.11.003
– volume: 110
  start-page: 1701
  year: 1992
  ident: 10.12997/jla.2020.9.3.406_ref42
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1992.01080240041025
– volume: 20
  start-page: 385
  year: 2001
  ident: 10.12997/jla.2020.9.3.406_ref58
  publication-title: Prog Retin Eye Res
  doi: 10.1016/S1350-9462(00)00025-2
– volume: 28
  start-page: 393
  year: 2009
  ident: 10.12997/jla.2020.9.3.406_ref37
  publication-title: Prog Retin Eye Res
  doi: 10.1016/j.preteyeres.2009.08.001
– volume: 111
  start-page: 1169
  year: 2004
  ident: 10.12997/jla.2020.9.3.406_ref63
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2003.10.024
– volume: 41
  start-page: 316
  year: 2010
  ident: 10.12997/jla.2020.9.3.406_ref91
  publication-title: Ophthalmic Surg Lasers Imaging
  doi: 10.3928/15428877-20100430-04
– volume: 109
  start-page: 420
  year: 1991
  ident: 10.12997/jla.2020.9.3.406_ref29
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1991.01080030122052
– volume: 118
  start-page: 351
  year: 2000
  ident: 10.12997/jla.2020.9.3.406_ref47
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.118.3.351
– volume: 40
  start-page: 209
  year: 2008
  ident: 10.12997/jla.2020.9.3.406_ref89
  publication-title: Ann Med
  doi: 10.1080/07853890701749209
– volume: 8
  start-page: e83759
  year: 2013
  ident: 10.12997/jla.2020.9.3.406_ref62
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0083759
– volume: 117
  start-page: 1989
  year: 2010
  ident: 10.12997/jla.2020.9.3.406_ref43
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2010.07.009
– volume: 1
  start-page: 1321
  year: 1962
  ident: 10.12997/jla.2020.9.3.406_ref84
  publication-title: Lancet
  doi: 10.1016/S0140-6736(62)92422-4
– volume: 224
  start-page: 493
  year: 1986
  ident: 10.12997/jla.2020.9.3.406_ref25
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/BF02154735
– volume: 13
  start-page: e0196037
  year: 2018
  ident: 10.12997/jla.2020.9.3.406_ref52
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0196037
– volume: 15
  start-page: 113
  year: 2001
  ident: 10.12997/jla.2020.9.3.406_ref97
  publication-title: J Diabetes Complications
  doi: 10.1016/S1056-8727(01)00140-4
– volume: 376
  start-page: 124
  year: 2010
  ident: 10.12997/jla.2020.9.3.406_ref66
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)62124-3
– volume: 106
  start-page: 3143
  year: 2002
  ident: 10.12997/jla.2020.9.3.406_ref3
  publication-title: Circulation
  doi: 10.1161/circ.106.25.3143
– volume: 326
  start-page: 97
  year: 2002
  ident: 10.12997/jla.2020.9.3.406_ref48
  publication-title: Clin Chim Acta
  doi: 10.1016/S0009-8981(02)00288-7
– volume: 117
  start-page: 766
  year: 2010
  ident: 10.12997/jla.2020.9.3.406_ref81
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2009.09.005
– volume: 50
  start-page: S15
  year: 2009
  ident: 10.12997/jla.2020.9.3.406_ref9
  publication-title: J Lipid Res
  doi: 10.1194/jlr.R800054-JLR200
– volume: 372
  start-page: 1835
  year: 2008
  ident: 10.12997/jla.2020.9.3.406_ref19
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)61759-6
– volume: 100
  start-page: 301
  year: 2002
  ident: 10.12997/jla.2020.9.3.406_ref14
  publication-title: Trans Am Ophthalmol Soc
– volume: 98
  start-page: 786
  year: 1991
  ident: 10.12997/jla.2020.9.3.406_ref69
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(13)38012-9
– volume: 6
  start-page: 346
  year: 2013
  ident: 10.12997/jla.2020.9.3.406_ref78
  publication-title: Int J Ophthalmol
– volume: 364
  start-page: 937
  year: 2004
  ident: 10.12997/jla.2020.9.3.406_ref2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)17018-9
– volume: 17
  start-page: 458
  year: 1968
  ident: 10.12997/jla.2020.9.3.406_ref85
  publication-title: Diabetes
  doi: 10.2337/diab.17.7.458
– volume: 8
  start-page: 117
  year: 1980
  ident: 10.12997/jla.2020.9.3.406_ref28
  publication-title: Aust J Ophthalmol
  doi: 10.1111/j.1442-9071.1980.tb01670.x
– volume: 121
  start-page: 1151
  year: 2003
  ident: 10.12997/jla.2020.9.3.406_ref64
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.121.8.1151
– volume: 44
  start-page: 720
  year: 2004
  ident: 10.12997/jla.2020.9.3.406_ref4
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2004.07.001
– volume: 133
  start-page: 503
  year: 2015
  ident: 10.12997/jla.2020.9.3.406_ref79
  publication-title: JAMA Ophthalmol
  doi: 10.1001/jamaophthalmol.2014.5108
– volume: 2
  start-page: 894
  year: 2014
  ident: 10.12997/jla.2020.9.3.406_ref87
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(14)70173-1
– volume: 56
  start-page: 1
  year: 2002
  ident: 10.12997/jla.2020.9.3.406_ref92
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/S0168-8227(01)00341-2
– volume: 8
  start-page: 103
  year: 1988
  ident: 10.12997/jla.2020.9.3.406_ref35
  publication-title: Arteriosclerosis
  doi: 10.1161/01.ATV.8.2.103
– volume: 83
  start-page: 465
  year: 2006
  ident: 10.12997/jla.2020.9.3.406_ref6
  publication-title: Exp Eye Res
  doi: 10.1016/j.exer.2005.11.018
– volume-title: Dyslipidemia and its role in the pathogenesis of atherosclerotic cardiovascular disease: implications for evaluation and targets for treatment of dyslipidemia based on recent guidelines
  year: 2019
  ident: 10.12997/jla.2020.9.3.406_ref10
– volume: 83
  start-page: 358
  year: 1999
  ident: 10.12997/jla.2020.9.3.406_ref22
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.83.3.358
– volume: 2
  start-page: e106
  year: 2014
  ident: 10.12997/jla.2020.9.3.406_ref17
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(13)70145-1
– volume: 82
  start-page: 844
  year: 2004
  ident: 10.12997/jla.2020.9.3.406_ref18
  publication-title: Bull World Health Organ
– volume: 4
  start-page: 977
  year: 2005
  ident: 10.12997/jla.2020.9.3.406_ref55
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd1901
– volume: 60
  start-page: 324
  year: 1976
  ident: 10.12997/jla.2020.9.3.406_ref27
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.60.5.324
– volume: 363
  start-page: 233
  year: 2010
  ident: 10.12997/jla.2020.9.3.406_ref94
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1001288
– volume: 114
  start-page: E7545
  year: 2017
  ident: 10.12997/jla.2020.9.3.406_ref51
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1620898114
– volume: 317
  start-page: 703
  year: 1998
  ident: 10.12997/jla.2020.9.3.406_ref73
  publication-title: BMJ
  doi: 10.1136/bmj.317.7160.703
SSID ssj0000942067
Score 2.1536176
SecondaryResourceType review_article
Snippet Dyslipidemia refers to an abnormal amount of lipid in the blood, and the total cholesterol level is defined as the sum of high-density lipoprotein cholesterol,...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 406
SubjectTerms Review
내과학
Title REvisiting Lipids in REtinal Diseases: A Focused Review on Age-related Macular Degeneration and Diabetic Retinopathy
URI https://www.ncbi.nlm.nih.gov/pubmed/33024733
https://www.proquest.com/docview/2449177403
https://pubmed.ncbi.nlm.nih.gov/PMC7521975
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002626964
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 지질·동맥경화학회지, 2020, 9(3), , pp.406-418
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbYeOEFAeNSNiaDEA-glCTOxeatoq3KNAYardQ3K3Hckq0kU5s-wK_n-JIsKRMavKSV48aWv6_Od-xzjhF6TUPXTUC1OfA2EU6QJgsn9ZlwpBuBAPZYwqgKcP58Fk1mwck8nNdHwtvokirti183xpX8D6pQBriqKNl_QLZ5KBTAd8AXroAwXG-F8flIhYZXJlDpKje-reejSp90NTRbLxsTez4uxXYjszqRPmA-WEpHR7JI5Wlh3FGHcqnTUFeNk7JemtXO9vDUUp1f3NkHbunZleqByf2qRGW5gc7CNW9E-1frlv1t--4kL3ZLh-rQo0nZXoUAk7N2s7KTlQ-WlwPGW2dmZS0CkdYsGegkA3_O3vBqVBvIFyuVEMp3-6xP-rZuN1P22Rc-np2e8uloPt1Dd_041lv09UrNhfGYVJnp1dmCddfsprZq5f1uGx1ZslesFzdZHLuOsy0lMn2A7tshxwPDh4fojiweoYNBkVTlj5_4DdZOvXq35ABV1xTBhiI4L7ClCK4p8gEPsCUINgTBZYFbBMGWILhNEAxY45oguEWQx2g2Hk0_Thx70IYjSEAjGBwRewmMlidhghbEzRYCdMqCJCEUBMJNkkyEEfUzSqOIZguPZknqyzDKWCxB0T9B-0VZyGcIE1DoAlR9GkZp4KURTaEiGOWuCBOapqyH3HqcubBZ6NVhKCuurFEFDQdouIKGM044QNNDb5ufXJkULH-r_ArA45ci5ypxuvpclvxyzcE8_MRZCNMS9XvoZY0th9lUbZElhSy3Gw5il3lgEbmkh54arJs2CQE9GxO4E3dY0FRQDXbvFPl3nbE9BpHM4vD5Ldo9RPeu_19HaL9ab-UL0L1VeqzXi441zX8DqvSv7A
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=REvisiting+Lipids+in+REtinal+Diseases%3A+A+Focused+Review+on+Age-related+Macular+Degeneration+and+Diabetic+Retinopathy&rft.jtitle=Journal+of+lipid+and+atherosclerosis&rft.au=Park%2C+Su+Jin&rft.au=Park%2C+Dong+Ho&rft.date=2020-09-01&rft.issn=2287-2892&rft.volume=9&rft.issue=3&rft.spage=406&rft_id=info:doi/10.12997%2Fjla.2020.9.3.406&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-2892&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-2892&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-2892&client=summon